Accessibility Menu
Nu Skin Enterprises logo

Nu Skin Enterprises(NYSE) NUS

Market Cap$254.89MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1996)-64%
5 Year-88%
1 Year-39%
1 Month-1%
$5.28
+0.48%
+0.02Today
Nu Skin Enterprises last closing stock price
MetricPriceDate
Last closeUSD 5.252026-07-28
Nu Skin Enterprises stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.19%USD 5.262026-07-21
1 month-0.57%USD 5.282026-06-26
3 month-25.73%USD 7.072026-04-29
Year to date-44.49%USD 9.462025-12-31
1 year-39.28%USD 8.652025-07-28
3 year-80.48%USD 26.902023-07-28
5 year-88.43%USD 45.372021-07-29
Since inception-63.74%USD 14.481996-11-22

Nu Skin Enterprises Financials at a Glance

Market Cap

$254.89MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.44B

Net Income (TTM)

$54.53M

EPS (TTM)

$1.09

P/E Ratio

4.80

Dividend

$0.24

Beta (Volatility)

0.90 (Low)

Price

$5.28

Volume

443,051

Open

$5.22

Previous Close

$5.29

Daily Range

$5.15 - $5.31

52-Week Range

$4.89 - $14.62

Estimated Earnings Date

Aug 10, 2026

NUS: Motley Fool Moneyball Superscore

39

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nu Skin Enterprises

Nu Skin makes beauty and health products for people wanting to look and feel better. It sells these items directly to customers through a global network of independent sellers. The company helps people start their own small businesses by selling skin care and supplements.

What Is in the Bag?

  • Wellness Products: Nutritional supplements like LifePak and weight management systems; generated 46.4% of revenue in 2025.
  • Beauty Products: Anti-aging skin care systems and cosmetic devices like ageLOC LumiSpa; accounted for 38.3% of revenue in 2025.
  • Connected Devices: Data-enabled handheld tools that provide personalized skin and wellness insights through a mobile application.
  • Rhyz Businesses: Manufacturing and technology services for internal brands and external clients; contributed 15.3% of 2025 revenue.

Strategic Moves and Changes

  • Formed Rhyz Inc. in 2018 to acquire companies that improve supply chain speed and diversify revenue.
  • Acquired Beauty Biosciences LLC to add retail and digital beauty channels to the corporate portfolio.
  • Sold Mavely in January 2025 as part of an effort to optimize the business structure.
  • Commenced pre-market activities in India during late 2025 to establish infrastructure for future growth.

The Social Selling Model

The company operates in nearly 50 markets using a network of independent affiliates who sell products through social platforms. It integrates scientific research with in-house manufacturing to develop proprietary anti-aging technologies and connected beauty devices.

Checking the Books

  • Revenue reached $370.3 million in Q4 2025, down 16.9% from the previous year.
  • Operating income turned positive at $23.2 million in Q4 2025, improving from a loss of $53.1 million in Q4 2024.
  • Net income hit $14.5 million in Q4 2025, which improved from a loss of $36.1 million a year earlier.
  • Free cash flow was $5.9 million in Q4 2025, a 55.6% decrease from Q4 2024.

Bottom Line

Nu Skin is moving from traditional direct selling to a digital-first model focused on personalized beauty devices. Its expansion into manufacturing helps control costs while entering new international markets.

AI Generated • May 8, 2026

Industry

Personal Products

Employees

8,600

CEO

Ryan S. Napierski, MBA

Headquarters

Provo, UT 84601, US

NUS Financials

Key Financial Metrics (TTM)

Gross Margin

69.31%

Operating Margin

5.66%

Net Income Margin

3.78%

Return on Equity

6.84%

Return on Capital

7.77%

Return on Assets

3.96%

Earnings Yield

20.83%

Dividend Yield

4.57%

Payout Ratio

21.47%

Stock Overview

Market Cap

$254.89MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

48.55M

Volume

443.05K

Avg. Volume

716.55K

Financials (TTM)

Gross Profit

$998.90M

Operating Income

$81.53M

EBITDA

$129.51M

Operating Cash Flow

$75.98M

Capital Expenditure

-$34.41M

Free Cash Flow

$41.57M

Cash & ST Invst.

$200.41M

Total Debt

$277.61M

Nu Skin Enterprises Performance Analysis

Nu Skin Enterprises annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 2,225,659,000-17.4%
20232023-12-31USD 1,969,131,000-11.5%
20242024-12-31USD 1,732,084,000-12.0%
20252025-12-31USD 1,485,159,000-14.3%
Nu Skin Enterprises sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-305.9%
Q32025-09-30-5.7%
Q42025-12-311.7%
Q12026-03-31-13.4%
Nu Skin Enterprises annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 2.07-27.6%
20232023-12-31USD 0.17-91.7%
20242024-12-31USD -2.95N/A
20252025-12-31USD 3.18N/A
Nu Skin Enterprises sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-79.9%
Q32025-09-30-20.9%
Q42025-12-31-14.7%
Q12026-03-31-87.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$320.61M

-12.0%

Gross Profit

$214.46M

-13.2%

Gross Margin

66.89%

N/A

Market Cap

$254.89MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$91.03K

N/A

Employees

2,800

N/A

Net Income

$1.84M

-98.3%

EBITDA

$19.19M

-87.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$200.41M

-6.2%

Total Debt

$277.61M

-7.7%

Accounts Receivable

$45.01M

-20.4%

Inventory

$178.60M

-5.4%

Long Term Debt

$257.61M

-8.2%

Short Term Debt

$20.00M

+0.0%

Return on Assets

3.96%

N/A

Return on Invested Capital

7.28%

N/A

Free Cash Flow

-$17.63M

-33.6%

Operating Cash Flow

-$3.92M

-1107.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BYNDBeyond Meat, Inc.
$0.53-1.94%
VSTAVasta Platform Limited
$4.90-1.61%
MGPIMGP Ingredients, Inc.
$18.88+0.91%
OTLYOatly Group AB
$15.26+0.66%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOFISoFi Technologies
$15.25-0.09%
INTCIntel
$81.88-0.05%
NVDANvidia
$190.01-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$57.75-0.06%

Questions About NUS

What is the current price of Nu Skin Enterprises?

Nu Skin Enterprises is trading at $5.29 per share.

What is the 52-week range for Nu Skin Enterprises?

Over the past 52 weeks, Nu Skin Enterprises has traded between $4.89 and $14.62.

How much debt does Nu Skin Enterprises have?

As of the most recent reporting period, Nu Skin Enterprises reported total debt of $277.61M.

How much cash does Nu Skin Enterprises have on hand?

Nu Skin Enterprises reported $198.65M in cash and cash equivalents in its most recent financial results.

What is Nu Skin Enterprises’s dividend yield?

Nu Skin Enterprises currently has a dividend yield of 4.57%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.